Brigit Biofarmaka Teknologi Tbk. vs Surya Fajar Capital Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Surya Fajar Capital Tbk. trades at Rp1,950 (market cap 2.67T, 31.6K 24h volume). The key difference: Surya Fajar Capital Tbk. is far larger — about 15.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 31.6K). Which is the better fit depends on your goals.
| OBAT | SFAN | |
|---|---|---|
Market Cap | 172.82B | 2.67T |
Volume | 592.2K | 31.6K |
Lot | 5.92K | 316 |
Turnover | 147.05M | 61.56M |
Average Price | 248.31 | 1,947.94 |
Value | 147.05M | 61.56M |
Indicative Equilibrium Price | 254 | — |
Indicative Equilibrium Volume | 10 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.
Read more on SFAN →